Metropolitan Life Insurance Company (MetLife)’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-63
| Closed | -$6.76K | – | 2406 |
|
|
2023
Q2 | $6.76K | Hold |
63
| – | – | ﹤0.01% | 2434 |
|
|
2023
Q1 | $18.9K | Sell |
63
-19
| -23% | -$5.71K | ﹤0.01% | 1910 |
|
|
2022
Q4 | $28K | Hold |
82
| – | – | ﹤0.01% | 1823 |
|
|
2022
Q3 | $15.4K | Hold |
82
| – | – | ﹤0.01% | 2143 |
|
|
2022
Q2 | $17.2K | Hold |
82
| – | – | ﹤0.01% | 2111 |
|
|
2022
Q1 | $27.3K | Sell |
82
-223
| -73% | -$74.2K | ﹤0.01% | 1936 |
|
|
2021
Q4 | $99.3K | Hold |
305
| – | – | ﹤0.01% | 2488 |
|
|
2021
Q3 | $148K | Buy |
305
+57
| +23% | +$27.7K | ﹤0.01% | 2297 |
|
|
2021
Q2 | $115K | Buy |
248
+35
| +16% | +$16.3K | ﹤0.01% | 2520 |
|
|
2021
Q1 | $147K | Hold |
213
| – | – | ﹤0.01% | 2223 |
|
|
2020
Q4 | $157K | Hold |
213
| – | – | ﹤0.01% | 2104 |
|
|
2020
Q3 | $147K | Hold |
213
| – | – | ﹤0.01% | 1974 |
|
|
2020
Q2 | $180K | Buy |
213
+178
| +509% | +$151K | ﹤0.01% | 1870 |
|
|
2020
Q1 | $12.4K | Buy |
+35
| New | +$12.4K | ﹤0.01% | 2480 |
|